Callan Family Office LLC Purchases Shares of 874 CorVel Co. (NASDAQ:CRVL)

Callan Family Office LLC acquired a new stake in CorVel Co. (NASDAQ:CRVL) during the third quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 874 shares of the business services provider’s stock, valued at approximately $286,000.

Other institutional investors also recently modified their holdings of the company. Janus Henderson Group PLC boosted its stake in shares of CorVel by 997.8% in the 1st quarter. Janus Henderson Group PLC now owns 46,975 shares of the business services provider’s stock valued at $12,351,000 after purchasing an additional 42,696 shares during the last quarter. Quadrature Capital Ltd bought a new stake in shares of CorVel in the 4th quarter valued at $887,000. SG Americas Securities LLC bought a new stake in shares of CorVel in the 1st quarter valued at $896,000. Sei Investments Co. boosted its stake in shares of CorVel by 65.8% in the 1st quarter. Sei Investments Co. now owns 21,003 shares of the business services provider’s stock valued at $5,523,000 after purchasing an additional 8,338 shares during the last quarter. Finally, Assenagon Asset Management S.A. boosted its stake in shares of CorVel by 41.8% in the 2nd quarter. Assenagon Asset Management S.A. now owns 115,876 shares of the business services provider’s stock valued at $29,464,000 after purchasing an additional 34,155 shares during the last quarter. 51.36% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Separately, StockNews.com lowered shares of CorVel from a “buy” rating to a “hold” rating in a research note on Saturday, August 31st.

CorVel Stock Up 1.1 %

Shares of NASDAQ CRVL opened at $312.79 on Wednesday. The firm has a market cap of $5.37 billion, a PE ratio of 71.09 and a beta of 1.08. CorVel Co. has a 12-month low of $187.92 and a 12-month high of $329.23. The company’s fifty day simple moving average is $311.40 and its 200 day simple moving average is $274.88.

CorVel (NASDAQ:CRVL) last issued its earnings results on Tuesday, July 30th. The business services provider reported $1.25 earnings per share (EPS) for the quarter. The business had revenue of $211.72 million for the quarter. CorVel had a net margin of 9.55% and a return on equity of 32.25%.

Insiders Place Their Bets

In other CorVel news, VP Jennifer Yoss sold 1,214 shares of the company’s stock in a transaction on Thursday, August 1st. The shares were sold at an average price of $300.88, for a total transaction of $365,268.32. Following the transaction, the vice president now owns 680 shares in the company, valued at approximately $204,598.40. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. In other news, CEO Michael G. Combs sold 2,473 shares of the stock in a transaction dated Monday, August 12th. The shares were sold at an average price of $300.99, for a total value of $744,348.27. Following the completion of the sale, the chief executive officer now owns 16,823 shares in the company, valued at $5,063,554.77. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, VP Jennifer Yoss sold 1,214 shares of the stock in a transaction dated Thursday, August 1st. The shares were sold at an average price of $300.88, for a total transaction of $365,268.32. Following the completion of the sale, the vice president now owns 680 shares of the company’s stock, valued at approximately $204,598.40. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 61,782 shares of company stock worth $17,178,624. Insiders own 47.57% of the company’s stock.

About CorVel

CorVel Corporation provides workers’ compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.